CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 8 analysts with an average price target of $60.51. This is a potential upside of $23.53 (63.63%) from yesterday's end of day stock price of $36.98.

Crinetics Pharmaceuticals's activity chart (see below) currently has 23 price targets and 65 ratings on display. The stock rating distribution of CRNX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.22% with an average time for these price targets to be met of 377.7 days.

Highest price target for CRNX is $90, Lowest price target is $54, average price target is $60.51.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 13-Jan-2025. First documented stock forecast 13-Aug-2018.

Currently out of the existing stock ratings of CRNX, 50 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$81

$44.02 (119.04%)

$81

26 days ago
(13-Jan-2025)

13/16 (81.25%)

$42.02 (107.80%)

322

Buy

$87

$50.02 (135.26%)

$80

1 months 23 days ago
(16-Dec-2024)

9/14 (64.29%)

$33.68 (63.17%)

394

Buy

$90

$53.02 (143.37%)

$65

4 months 23 days ago
(16-Sep-2024)

3/6 (50%)

$36.06 (66.85%)

131

Buy

$73

$36.02 (97.40%)

$74

5 months 30 days ago
(09-Aug-2024)

4/6 (66.67%)

$25.36 (53.23%)

130

Buy

$54

$17.02 (46.02%)

$35

6 months 30 days ago
(09-Jul-2024)

8/8 (100%)

$5.77 (11.96%)

203

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 377.7 days on average for the stock forecasts to be realized with a an average price target met ratio 69.22

Which analyst has the current highest performing score on CRNX (Crinetics Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 11 price targets and 8 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Josh Schimmer with highest potential upside - $53.02

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?